Friso W. A. Hoefnagels

Friso W. A. Hoefnagels

Auto-generated profile, based on publicly available information

Friso W. A. Hoefnagels

Department Neurology, Amsterdam UMC Location AMC, University of Amsterdam, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2009 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
FHFriso W. A. Hoefnagels
Friso W. A. Hoefnagels
FLFrank Lagerwaard
Frank Lagerwaard
ESEsther Sanchez
Esther Sanchez
CHCornelis J. A. Haasbeek
Cornelis J. A. Haasbeek
DKDirk L. Knol
Dirk L. Knol
WVW. Peter Vandertop
W. Peter Vandertop
To assess the capability of perfusion MRI to differentiate between necrosis and tumor recurrence in patients showing radiological progression of cerebral metastases treated with stereotactic radiosurgery (SRS). From 2004 to 2006 dynamic susceptibility-weighted contrast-enhanced perfusion MRI scans were performed on patients with cerebral metastasis showing radiological progression after SRS during follow-up. Several perfusion MRI characteristics were examined: a subjective visual score of the relative cerebral blood volume (rCBV) map and quantitative rCBV measurements of the contrast-enhanced areas of maximal perfusion. For a total of 34 lesions in 31 patients a perfusion MRI was performed. Diagnoses were based on histology, definite radiological decrease or a combination of radiological and clinical follow-up. The diagnosis of tumor recurrence was obtained in 20 of 34 lesions, and tumor necrosis in 14 of 34. Regression analyses for all measures proved statistically significant (χ2 = 11.6–21.6, P < 0.001–0.0001). Visual inspection of the rCBV map yielded a sensitivity and specificity of 70.0 respectively 92.9%. The optimal cutoff point for maximal tumor rCBV relative to white matter was 2.00 (improving the sensibility to 85.0%) and 1.85 relative to grey matter (GM), improving the specificity to 100%, with a corresponding sensitivity of 70.0%. Perfusion MRI seems to be a useful tool in the differentiation of necrosis and tumor recurrence after SRS. For the patients displaying a rCBV-GM greater than 1.85, the diagnosis of necrosis was excluded. Salvage treatment can be initiated for these patients in an attempt to prolong survival.

7 September 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
NVN. Verburg
N. Verburg
FHF.W.A. Hoefnagels
F.W.A. Hoefnagels
FBF. Barkhof
F. Barkhof
RBR. Boellaard
R. Boellaard
SGS. Goldman
S. Goldman
AAA A
A A
BACKGROUND: Brain imaging in diffuse glioma is used for diagnosis, treatment planning, and follow-up. PURPOSE: In this meta-analysis, we address the diagnostic accuracy of imaging to delineate diffuse glioma. DATA SOURCES: We systematically searched studies of adults with diffuse gliomas and correlation of imaging with histopathology. STUDY SELECTION: Study inclusion was based on quality criteria. Individual patient data were used, if available. DATA ANALYSIS: A hierarchic summary receiver operating characteristic method was applied. Low- and high-grade gliomas were analyzed in subgroups. DATA SYNTHESIS: Sixty-one studies described 3532 samples in 1309 patients. The mean Standard for Reporting of Diagnostic Accuracy score (13/25) indicated suboptimal reporting quality. For diffuse gliomas as a whole, the diagnostic accuracy was best with T2-weighted imaging, measured as area under the curve, false-positive rate, true-positive rate, and diagnostic odds ratio of 95.6%, 3.3%, 82%, and 152. For low-grade gliomas, the diagnostic accuracy of T2-weighted imaging as a reference was 89.0%, 0.4%, 44.7%, and 205; and for high-grade gliomas, with T1-weighted gadolinium-enhanced MR imaging as a reference, it was 80.7%, 16.8%, 73.3%, and 14.8. In high-grade gliomas, MR spectroscopy (85.7%, 35.0%, 85.7%, and 12.4) and 11C methionine–PET (85.1%, 38.7%, 93.7%, and 26.6) performed better than the reference imaging. LIMITATIONS: True-negative samples were underrepresented in these data, so false-positive rates are probably less reliable than true-positive rates. Multimodality imaging data were unavailable. CONCLUSIONS: The diagnostic accuracy of commonly used imaging is better for delineation of low-grade gliomas than high-grade gliomas on the basis of limited evidence. Improvement is indicated from advanced techniques, such as MR spectroscopy and PET.

18 February 2011 in European Radiology
Verified
Journal Article
Open access
PDF file
SBSinan M. K. Belhawi
Sinan M. K. Belhawi
FHFriso W. A. Hoefnagels
Friso W. A. Hoefnagels
JBJohannes C. Baaijen
Johannes C. Baaijen
EAEsther Sanchez Aliaga
Esther Sanchez Aliaga
JRJaap C. Reijneveld
Jaap C. Reijneveld
AAA A
A A
Background Standards for residual tumour measurement after resection of gliomas with no or minimal enhancement have not yet been established. In this study residual volumes on early and late postoperative T2-/FLAIR-weighted MRI are compared. Methods A retrospective cohort included 58 consecutive glioma patients with no or minimal preoperative gadolinium enhancement. Inclusion criteria were first-time resection between 2007 and 2009 with a T2-/FLAIR-based target volume and availability of preoperative, early (<48 h) and late (1–7 months) postoperative MRI. The volumes of non-enhancing T2/FLAIR tissue and diffusion restriction areas were measured. Results Residual tumour volumes were 22% smaller on late postoperative compared with early postoperative T2-weighted MRI and 49% smaller for FLAIR-weighted imaging. Postoperative restricted diffusion volume correlated with the difference between early and late postoperative FLAIR volumes and with the difference between T2 and FLAIR volumes on early postoperative MRI. Conclusion We observed a systematic and substantial overestimation of residual non-enhancing volume on MRI within 48 h of resection compared with months postoperatively, in particular for FLAIR imaging. Resection-induced ischaemia contributes to this overestimation, as may other operative effects. This indicates that early postoperative MRI is less reliable to determine the extent of non-enhancing residual glioma and restricted diffusion volumes are imperative.

31 July 2014 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
FHFriso W. A. Hoefnagels
Friso W. A. Hoefnagels
AAA A
A A
ESErnesto Sanz-Arigita
Ernesto Sanz-Arigita
SISander Idema
Sander Idema
JKJoost P. A. Kuijer
Joost P. A. Kuijer
WVW. Peter Vandertop
W. Peter Vandertop

19 November 2021 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
JSJuliana F Sabelis
Juliana F Sabelis
SYStephen A.L.Y. Youssef
Stephen A.L.Y. Youssef
FHFriso W.A. Hoefnagels
Friso W.A. Hoefnagels
ABAlfred G Becking
Alfred G Becking
RSRuud Schreurs
Ruud Schreurs
LDLeander Dds Dubois
Leander Dds Dubois
Orbital reconstruction is one of the most complex procedures in maxillofacial surgery. It becomes even more complex when all references to the original anatomy are lost. The purpose of this article is to provide an overview of techniques for complex three- and four-wall orbital reconstructions. Preoperative virtual surgical planning is essential when considering different reconstruction possibilities. The considerations that may lead to different approaches are described, and the advantages and drawbacks of each technique are evaluated. It is recommended to reconstruct solitary three-wall or four-wall orbital defects with multiple patientspecific implants. Optimizations of this treatment protocol are suggested, and their effects on predictability are demonstrated in a case presentation of a four-wall defect reconstruction with multiple patient-specific implants.